WallStSmart

Healthcare Triangle Inc (HCTI)vsVeeva Systems Inc Class A (VEEV)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Veeva Systems Inc Class A generates 16461% more annual revenue ($3.32B vs $20.04M). VEEV leads profitability with a 28.4% profit margin vs -69.7%. VEEV earns a higher WallStSmart Score of 64/100 (C+).

HCTI

Hold

41

out of 100

Grade: D

Growth: 5.3Profit: 2.0Value: 5.0Quality: 4.5
Piotroski: 3/9Altman Z: -2.84

VEEV

Buy

64

out of 100

Grade: C+

Growth: 7.3Profit: 8.0Value: 6.7Quality: 9.0
Piotroski: 4/9Altman Z: 4.78
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for HCTI.

VEEVUndervalued (+38.7%)

Margin of Safety

+38.7%

Fair Value

$288.98

Current Price

$243.75

$45.23 discount

UndervaluedFair: $288.98Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HCTI3 strengths · Avg: 9.7/10
Price/BookValuation
0.1x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
166.1%10/10

Revenue surging 166.1% year-over-year

Debt/EquityHealth
0.219/10

Conservative balance sheet, low leverage

VEEV6 strengths · Avg: 9.2/10
Operating MarginProfitability
30.9%10/10

Strong operational efficiency at 30.9%

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.7810/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
28.4%9/10

Keeps 28 of every $100 in revenue as profit

Revenue GrowthGrowth
16.3%8/10

16.3% revenue growth

Free Cash FlowQuality
$1.13B8/10

Generating 1.1B in free cash flow

Areas to Watch

HCTI4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$2.53M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-26.5%2/10

ROE of -26.5% — below average capital efficiency

VEEV1 concerns · Avg: 2.0/10
P/E RatioValuation
44.8x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : HCTI

The strongest argument for HCTI centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 166.1% demonstrates continued momentum.

Bull Case : VEEV

The strongest argument for VEEV centers on Operating Margin, Debt/Equity, Altman Z-Score. Profitability is solid with margins at 28.4% and operating margin at 30.9%. Revenue growth of 16.3% demonstrates continued momentum.

Bear Case : HCTI

The primary concerns for HCTI are EPS Growth, Market Cap, Piotroski F-Score.

Bear Case : VEEV

The primary concerns for VEEV are P/E Ratio. A P/E of 44.8x leaves little room for execution misses.

Key Dynamics to Monitor

HCTI profiles as a hypergrowth stock while VEEV is a growth play — different risk/reward profiles.

HCTI carries more volatility with a beta of 1.12 — expect wider price swings.

HCTI is growing revenue faster at 166.1% — sustainability is the question.

VEEV generates stronger free cash flow (1.1B), providing more financial flexibility.

Bottom Line

VEEV scores higher overall (64/100 vs 41/100), backed by strong 28.4% margins and 16.3% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Healthcare Triangle Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Healthcare Triangle, Inc. is a healthcare information technology company. The company is headquartered in Pleasanton, California.

Veeva Systems Inc Class A

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. The company is headquartered in Pleasanton, California.

Visit Website →

Want to dig deeper into these stocks?